𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy

✍ Scribed by Michael M. Vickers; Toni K. Choueiri; Miranda Rogers; Andrew Percy; Daygen Finch; Ivan Zama; Tina Cheng; Scott North; Jennifer J. Knox; Christian Kollmannsberger; David F. McDermott; Brian I. Rini; Daniel Y. Heng

Book ID
116952287
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
190 KB
Volume
76
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical factors associated with outcome
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to